These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2162412

  • 1. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y, Kuwabara M, Iwakoshi N, Kito K.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K, Okura H.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract] [Full Text] [Related]

  • 3. [Evaluation of KMO1 for the gastrointestinal disease].
    Okumura S, Ohyanagi H, Saitoh Y.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical significance of CA 195 assay as a tumor marker].
    Ohkura H, Sakawaki T.
    Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T, Morimoto H, Saito M, Mori T.
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
    Sawabu N, Satomura Y.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical significance of YH-206 assay analysis as a tumor marker].
    Yachi A, Hinoda Y, Imai K, Endo T.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical significance of CA 50 assay as a tumor marker].
    Hara K, Mitsuhashi F, Ohkura H.
    Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Early diagnostic system of minute hepatocellular carcinoma, and neoplasms of biliary tract and pancreas].
    Okuda K, Tsuchiya Y, Saisho H.
    Nihon Rinsho; 1982 Feb; 40(1):146-50. PubMed ID: 6283199
    [No Abstract] [Full Text] [Related]

  • 15. A new monoclonal-antibody-defined tumor marker (KMO1) for pancreatic carcinoma.
    Ohyanagi H, Saitoh Y, Okumura S, Ishida T, Uesaka K, Ishida H, Yamamoto M, Uemura Y, Kano Y, Suyama T.
    Mt Sinai J Med; 1987 Jun; 54(5):393-400. PubMed ID: 3498891
    [No Abstract] [Full Text] [Related]

  • 16. [Tumor markers for hepatoma and carcinoma of biliary tract].
    Higashino K.
    Rinsho Byori; 1985 Aug; 33(8):861-71. PubMed ID: 2416966
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.